ZA954892B - Novel cell system having specific interaction of peptide binding pairs - Google Patents

Novel cell system having specific interaction of peptide binding pairs

Info

Publication number
ZA954892B
ZA954892B ZA954892A ZA954892A ZA954892B ZA 954892 B ZA954892 B ZA 954892B ZA 954892 A ZA954892 A ZA 954892A ZA 954892 A ZA954892 A ZA 954892A ZA 954892 B ZA954892 B ZA 954892B
Authority
ZA
South Africa
Prior art keywords
peptide
transcriptional activation
fusion protein
protein
host cell
Prior art date
Application number
ZA954892A
Other languages
English (en)
Inventor
Kathleen H Young
Bradley A Ozenberger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA954892B publication Critical patent/ZA954892B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mobile Radio Communication Systems (AREA)
ZA954892A 1994-06-14 1995-06-13 Novel cell system having specific interaction of peptide binding pairs ZA954892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/259,609 US5989808A (en) 1994-06-14 1994-06-14 Identification of compounds affecting specific interaction of peptide binding pairs

Publications (1)

Publication Number Publication Date
ZA954892B true ZA954892B (en) 1996-01-30

Family

ID=22985626

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954892A ZA954892B (en) 1994-06-14 1995-06-13 Novel cell system having specific interaction of peptide binding pairs

Country Status (18)

Country Link
US (3) US5989808A (de)
EP (1) EP0765389B1 (de)
AT (1) ATE245189T1 (de)
AU (1) AU706173B2 (de)
CA (1) CA2195083A1 (de)
DE (1) DE69531302T2 (de)
DK (1) DK0765389T3 (de)
ES (1) ES2202366T3 (de)
GE (1) GEP20022619B (de)
IL (1) IL114118A0 (de)
LT (1) LT4230B (de)
LV (1) LV11906B (de)
NZ (1) NZ287372A (de)
PT (1) PT765389E (de)
RU (1) RU2208646C2 (de)
SI (1) SI9520073B (de)
WO (1) WO1995034646A1 (de)
ZA (1) ZA954892B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226761B2 (en) * 1992-11-05 2007-06-05 Danisco Sweeteners Oy Manufacture of five-carbon sugars and sugar alcohols
US6891021B2 (en) 1993-02-12 2005-05-10 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
US6972193B1 (en) * 1993-02-12 2005-12-06 Board Of Trustees Of Leland Stanford Junior University Regulated transcription of targeted genes and other biological events
US6770446B1 (en) * 1994-06-14 2004-08-03 Wyeth Cell systems having specific interaction of peptide binding pairs
US5610015A (en) * 1995-03-23 1997-03-11 Wisconsin Alumni Research Foundation System to detect protein-RNA interactions
NZ306767A (en) * 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
CA2252886C (en) * 1996-04-26 2008-02-12 Massachusetts Institute Of Technology Three-hybrid screening assay
DE29724617U1 (de) * 1996-04-26 2002-06-13 Massachusetts Institute Of Technology, Cambridge, Mass. Drei-Hybrid-Kit zur Molekülauswahl
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
WO1997049808A1 (en) * 1996-06-27 1997-12-31 Biogen, Inc. The caip-like gene family
FR2761697B1 (fr) * 1997-04-03 1999-05-28 Inst Nat Sante Rech Med Methodes de detection d'interactions entre plusieurs proteines
DE19715683C2 (de) * 1997-04-15 1999-11-11 Max Planck Gesellschaft Neue Reportervektoren für One-Hybrid und Two-Hybrid Systeme
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
EP0977846B1 (de) 1997-04-25 2002-06-19 Wyeth Neuronale mort 1 isoformen
US6479653B1 (en) 1997-08-26 2002-11-12 Ariad Gene Therapeutics, Inc. Compositions and method for regulation of transcription
JP4296608B2 (ja) * 1997-08-27 2009-07-15 田辺三菱製薬株式会社 Ｐｐａｒのアゴニスト及びアンタゴニストのスクリーニング方法
EP1149920A1 (de) * 1997-10-15 2001-10-31 Diversa, Inc. Screening fÜr neue Verbindungen, die biologische Interaktionen regulieren
AU1094699A (en) * 1997-10-15 1999-05-03 Diversa Corporation Screening for novel compounds which regulate biological interactions
US6261842B1 (en) 1997-10-23 2001-07-17 Wisconsin Alumni Research Foundation Microorganism genomics, compositions and methods related thereto
WO1999025739A1 (en) * 1997-11-14 1999-05-27 Roche Diagnostics Corporation Variable region fusion peptides that form effector complexes in the presence of antigen
EP1053347B1 (de) 1998-01-09 2007-02-28 Phylogica Limited Nachweisverfahren für peptide
EP0974649A1 (de) * 1998-06-22 2000-01-26 Universität Zürich Screening-System
US7166475B2 (en) 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
GB9907687D0 (en) * 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
EP1194756A4 (de) 1999-04-21 2004-12-29 Wyeth Corp Verfahren zur identifikation von modulatoren der inaktivierungvon n-typ-ionenkanälen
JP2004527204A (ja) * 2000-04-24 2004-09-09 ワイエス ペプチド結合対の特異的相互作用を有する新規な細胞系
DE60143959D1 (de) 2000-08-25 2011-03-10 Basf Plant Science Gmbh En kodieren
US20020165149A1 (en) * 2000-12-08 2002-11-07 Kranz David M. Mutated class II major histocompatibility proteins
DK1534819T3 (da) 2002-08-21 2010-04-19 Revivicor Inc Griselignende dyr, som mangler enhver ekspression af funktionel alfa-1,3-galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
US20070298414A1 (en) * 2003-11-17 2007-12-27 Doyle Donald F Engineering Enzymes Through Genetic Selection
EP1544307A1 (de) * 2003-12-18 2005-06-22 AXXAM S.r.l. Chimärer LAC9 Rezeptor und dessen Verwendungen
BRPI0513826A2 (pt) 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
EP3138403A1 (de) 2005-08-09 2017-03-08 Revivicor, Inc. Ctla4-ig exprimierende transgene huftiere und verwendungen davon
AU2007212390A1 (en) * 2006-02-07 2007-08-16 Wyeth Materials and methods for identifying agents that modulate Norrin, Norrin mimetics, and agents identified thereby
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN101131363B (zh) * 2007-09-30 2010-12-01 南京大学 一种基于酵母三杂交的小分子化合物检测方法
WO2016154452A2 (en) 2015-03-24 2016-09-29 Osiris Therapeutics, Inc. Compositions comprising meniscal tissues and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5322801A (en) * 1990-04-19 1994-06-21 The General Hospital Corporation Protein partner screening assays and uses thereof
WO1994010300A1 (en) * 1992-10-30 1994-05-11 The General Hospital Corporation Interaction trap system for isolating novel proteins
US5512473A (en) * 1993-01-29 1996-04-30 Brent; Roger Max-interacting proteins and related molecules and methods
US5582995A (en) * 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
EP0737314A4 (de) * 1993-12-30 1999-11-03 Salk Inst For Biological Studi Verwendungen für gal 4-rezeptor-konstrukte
ATE190984T1 (de) * 1994-01-21 2000-04-15 Icos Corp Materialien und methoden die sich auf mit casein kinase i wechselwirkende proteine beziehen
US5525490A (en) * 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
US5691147A (en) * 1994-06-02 1997-11-25 Mitotix, Inc. CDK4 binding assay

Also Published As

Publication number Publication date
PT765389E (pt) 2003-11-28
SI9520073B (sl) 2004-06-30
NZ287372A (en) 1997-11-24
EP0765389B1 (de) 2003-07-16
US6284519B1 (en) 2001-09-04
DK0765389T3 (da) 2003-10-27
LV11906B (en) 1998-06-20
CA2195083A1 (en) 1995-12-21
DE69531302D1 (de) 2003-08-21
WO1995034646A1 (en) 1995-12-21
GEP20022619B (en) 2002-01-25
SI9520073A (sl) 1998-02-28
ES2202366T3 (es) 2004-04-01
ATE245189T1 (de) 2003-08-15
LT4230B (en) 1997-10-27
RU2208646C2 (ru) 2003-07-20
AU2606695A (en) 1996-01-05
EP0765389A1 (de) 1997-04-02
LV11906A (lv) 1997-12-20
LT97004A (en) 1997-07-25
IL114118A0 (en) 1995-10-31
US6251602B1 (en) 2001-06-26
US5989808A (en) 1999-11-23
AU706173B2 (en) 1999-06-10
DE69531302T2 (de) 2004-04-22

Similar Documents

Publication Publication Date Title
ZA954892B (en) Novel cell system having specific interaction of peptide binding pairs
NZ332598A (en) Human BAS-1 protein, and use as an antagonist for modulating physiology or development of a cell
DK600486D0 (da) Igg-bindingsprotein
AU2705895A (en) Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
ATE238550T1 (de) Markierung und auswahl von molekülen
DE69836956D1 (de) Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält
WO1998049286A3 (en) Directed evolution of enzymes and antibodies
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
WO1999043808A8 (en) Human c-maf compositions and methods of use thereof
ES8801376A1 (es) Un procedimiento para preparar una proteina hibrida
CA2302147A1 (en) Methods for protein screening
NO962084L (no) DNA sekvens som koder for en BMP reseptor
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
Board Genetic heterogeneity of the B subunit of coagulation factor XIII: resolution of type 2
WO2001073028A3 (en) A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
WO2001094383A3 (en) Mutated furin polypeptides having improved characteristics
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
WO2002050104A3 (en) Methods and cells for detecting modulators of rgs proteins
DK0750637T3 (da) CAI resistens, som koder for et protein, samt anvendelse deraf
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
MX9603266A (es) Genes de timocina de mamiferos.
WO2000031133A3 (en) Potassium channel interactors and uses therefor
EA200300420A1 (ru) Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)
EP0688224A4 (de) Ein mutiertes protein und verfahren und materialien zu seiner herstellung und verwendung
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika